Company & Sponsor Intelligence

Brugmann University Hospital

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials3

Recruiting0

Completed2

Countries1

Therapeutic footprint

alzheimersmultiple_sclerosissubstance_use

Indexed studies

NCT05941975Multimodal Exploration of Patients With Multiple Sclerosis for an Early Detection of Subtle Progression
multiple_sclerosis · BelgiumNA

NCT04990375tDCS to Prevent Relapse in Alcohol Use Disorder
substance_use · BelgiumNA

NCT01505504Mirtazapine in Alzheimer-associated Weight Loss
alzheimers · BelgiumCOMPLETED

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →